Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Both compounds are available through research supply channels
The RevIVe Wellness Approach At RevIVe Wellness, peptides like BPC-157 are approached with the same standards as any medical therapy: education, precision, and patient-first care
RETATRUTIDE + CAGRILINTIDE Third-Party Tested COA Available A co-formulated research blend of Retatrutide (GIP/GLP-1/glucagon triple agonist) and Cagrilintide (amylin analogue) at 12.5 mg / 2.5 mg
Dihexa for Baby Brain & Postpartum Brain Fog Why baby brain is real: the Davies 2018 Medical Journal of Australia meta-analysis, the Hoekzema 2017 and Pritschet 2024 Nature Neuroscience maternal-brain remodelling studies, the postpartum estradiol-BDNF crash, the allopregnanolone / brexanolone / zuranolone (Zurzuvae, FDA Aug 2023) neurosteroid story, the dominant sleep, postpartum-thyroiditis and iron drivers, ONS 567,708 England births (2024) and the RCPsych July 2025 postnatal-depression estimate and why pregnancy and breastfeeding are absolute contraindications for an unlicensed HGF/c-Met peptide
- At 1 month, no significant improvement in phantom limb pain was observed compared to sham treatment
US$ 23.60
US$ 29.51
US$ 23.00
US$ 20.15
US$ 24.79
US$ 21.21